FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947882004> ?p ?o ?g. }

• W2947882004 abstract "Background Topical NSAIDs and paracetamol (APAP) are frequently used for osteoarthritis (OA) pain.1,2 In real-world settings, combination treatment is common,3,4 with more than one-quarter of patients using topical NSAIDs with oral non-opioid analgesics such as APAP.4 Objectives We conducted a systematic scoping review to: understand current recommendations on concomitant use of topical NSAIDs and APAP for OA pain; evaluate the extent of supporting evidence for this practice; and identify literature gaps. Methods We searched PubMed and the Cochrane Library for clinical studies (database inception to January 2019) of topical NSAIDs in OA in which APAP was given concomitantly, either regularly (combination treatment) or as needed (rescue treatment). Grey literature searches were conducted to identify clinical practice guidelines for management of OA from leading organizations. Results After removing duplicates, the literature searches returned 375 articles, of which 66 were clinical studies of topical NSAIDs in OA and were reviewed further. Of these, we identified 1 randomized controlled trial (RCT) evaluating efficacy and safety of combination treatment with APAP and a topical NSAID, in which 43 patients with knee OA currently treated with APAP were randomly assigned to double-blind treatment with ketoprofen plaster or placebo for 4 weeks.5 Results showed that the combination of APAP/topical ketoprofen was statistically significantly more effective in pain reduction (P=0.03) and physician’s global assessments (P=0.01) compared with APAP/placebo. Of the remaining 65 topical NSAID studies, another 37 (57%) allowed rescue treatment with APAP during the treatment period (including 34 RCTs; 1 open-label extension of 2 RCTs; 1 patient preference study; and 1 single-arm open clinical trial). Because none of these studies randomly assigned patients to the combination, it was not possible to evaluate efficacy or safety of the combination based on these data. Review of OA guidelines identified 3 major organizations—EULAR, NICE, and ESCEO—that recommend or allow concomitant use of topical NSAIDs and APAP for specific joints.6-8 Conclusion In clinical practice, drug combinations are frequently used to manage OA pain, and some OA treatment guidelines allow the use of topical NSAIDs concomitantly with APAP. Very limited supporting data are available, with only a single small RCT demonstrating the efficacy and safety of the combination. However, it may be inferred from the fact that more than half of the topical NSAID studies identified allowed APAP rescue therapy that this combination is generally perceived to be efficacious and well tolerated. Additional, larger RCTs are needed to confirm the benefit of this commonly used analgesic combination in managing OA pain. References [1] Conaghan PG, et al. Clin Rheumatol. 2015;34:1581-8. [2] Jackson H, et al. BMJ Open. 2017;7:e019694. [3] Gupta R, et al. Int J Res Med Sci. 2018;6:985-9. [4] Wilson N, et al. Rheumatology. 2015;54:860-7. [5] Yoo B, et al. J Korean Rheum Assoc. 1996;3:70-5. [6] Bruyere O, et al. Semin Arthritis Rheum. 2014;44:253-63. [7] Geenen R, et al. Ann Rheum Dis. 2018;77:797-807. [8] NICE. Guideline CG177. 2014. Disclosure of Interests John Bell Consultant for: John Bell has acted as consultant for Bayer, GlaxoSmithKline, Mylan, Novartis, Pfizer and Reckitt Benckiser., Speakers bureau: John Bell has received payment for speaking from GlaxoSmithKline, Pfizer and Reckitt Benckiser., Vidhu Sethi Employee of: Vidhu Sethi is an employee of GlaxoSmithKline Consumer Healthcare, Singapore., Kamran Siddiqui Employee of: Kamran Siddiqui is an employee of GlaxoSmithKline Consumer Healthcare, Singapore., Philip G Conaghan Consultant for: Flexion Therapeutics, AbbVie, Medivir, Merck Serono, Novartis, GlaxoSmithKline" @default.
• W2947882004 created "2019-06-07" @default.
• W2947882004 creator A5028596503 @default.
• W2947882004 creator A5029732990 @default.
• W2947882004 creator A5044470128 @default.
• W2947882004 creator A5072427161 @default.
• W2947882004 date "2019-06-01" @default.
• W2947882004 modified "2023-10-18" @default.
• W2947882004 title "AB0808 COMBINATION OF ORAL PARACETAMOL AND TOPICAL NSAIDS FOR OSTEOARTHRITIS PAIN: A SYSTEMATIC SCOPING REVIEW OF THE LITERATURE" @default.
• W2947882004 cites W1963909470 @default.
• W2947882004 doi "https://doi.org/10.1136/annrheumdis-2019-eular.7257" @default.
• W2947882004 hasPublicationYear "2019" @default.
• W2947882004 type Work @default.
• W2947882004 sameAs 2947882004 @default.
• W2947882004 citedByCount "1" @default.
• W2947882004 countsByYear W29478820042023 @default.
• W2947882004 crossrefType "proceedings-article" @default.
• W2947882004 hasAuthorship W2947882004A5028596503 @default.
• W2947882004 hasAuthorship W2947882004A5029732990 @default.
• W2947882004 hasAuthorship W2947882004A5044470128 @default.
• W2947882004 hasAuthorship W2947882004A5072427161 @default.
• W2947882004 hasBestOaLocation W29478820041 @default.
• W2947882004 hasConcept C142724271 @default.
• W2947882004 hasConcept C17744445 @default.
• W2947882004 hasConcept C1862650 @default.
• W2947882004 hasConcept C189708586 @default.
• W2947882004 hasConcept C199539241 @default.
• W2947882004 hasConcept C204787440 @default.
• W2947882004 hasConcept C2776164576 @default.
• W2947882004 hasConcept C2778722691 @default.
• W2947882004 hasConcept C2779473830 @default.
• W2947882004 hasConcept C2983098980 @default.
• W2947882004 hasConcept C42219234 @default.
• W2947882004 hasConcept C71924100 @default.
• W2947882004 hasConceptScore W2947882004C142724271 @default.
• W2947882004 hasConceptScore W2947882004C17744445 @default.
• W2947882004 hasConceptScore W2947882004C1862650 @default.
• W2947882004 hasConceptScore W2947882004C189708586 @default.
• W2947882004 hasConceptScore W2947882004C199539241 @default.
• W2947882004 hasConceptScore W2947882004C204787440 @default.
• W2947882004 hasConceptScore W2947882004C2776164576 @default.
• W2947882004 hasConceptScore W2947882004C2778722691 @default.
• W2947882004 hasConceptScore W2947882004C2779473830 @default.
• W2947882004 hasConceptScore W2947882004C2983098980 @default.
• W2947882004 hasConceptScore W2947882004C42219234 @default.
• W2947882004 hasConceptScore W2947882004C71924100 @default.
• W2947882004 hasLocation W29478820041 @default.
• W2947882004 hasOpenAccess W2947882004 @default.
• W2947882004 hasPrimaryLocation W29478820041 @default.
• W2947882004 hasRelatedWork W2047558187 @default.
• W2947882004 hasRelatedWork W2110920484 @default.
• W2947882004 hasRelatedWork W2146160905 @default.
• W2947882004 hasRelatedWork W2169446629 @default.
• W2947882004 hasRelatedWork W2400752691 @default.
• W2947882004 hasRelatedWork W2760944955 @default.
• W2947882004 hasRelatedWork W2905556635 @default.
• W2947882004 hasRelatedWork W3136913732 @default.
• W2947882004 hasRelatedWork W3157880528 @default.
• W2947882004 hasRelatedWork W3158906224 @default.
• W2947882004 isParatext "false" @default.
• W2947882004 isRetracted "false" @default.
• W2947882004 magId "2947882004" @default.
• W2947882004 workType "article" @default.